Solicitation will be issued separately. The National Cancer Institute (NCI) plans to procure services regarding an NCI pilot study: Obesity and Endometrial Cancer in Postmenopausal Women: Examining the Roles of Adiponectin, Leptin, Visfatin, and Estradiol. The supplies and services herein are being procured in accordance with the simplified acquisition procedures authorized by FAR Part 13.106. The North American Industry Classification System code is 541380 and the business size standard is $11M. Purpose: The National Cancer Institutes interest in this procurement is to measure adiponectin, leptin, visfatin, and estradiol in a series of endometrial cancer cases and controls. In this study, adiponectin, leptin, visfatin, and estradiol will be measured in serum by radioimmunoassay (RIA) and RIA with extraction and chromatography in endometrial cancer cases and controls enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) study. Approximately 160 endometrial cancer cases, 320 controls and an additional 50 blinded quality control samples. Period of Performance shall be twelve (12) months from date of award. Potential offerors may request a copy of the solicitation from Malinda Holdcraft, Contract Specialist via electronic mail at [email protected] or fax (301) 402-4513. If you have questions regarding this notice, they may be addressed to the aforementioned individual noted above. All potential offerors must provide the company name, DUNS number and business size standard; point of contact name, phone and fax numbers, email address and; complete mailing address. In order to receive an award, contractors must be registered in and have valid certification in the Central Contractor Registration (CCR) www.ccr.gov and the Online Representations and Certifications Applications (ORCA) www.bpn.orca.gov in order to receive an award. ESTIMATED ISSUE DATE of the solicitation is August 16, 2007 No collect calls will be accepted. Reference: RFQ-NCI-70109-NG on all correspondence.

Bid Protests Not Available